Samuel M Cohen

48PUBLICATIONS
80CO-AUTHORS
Predictive and prognostic markersAnimal physiology - systemsLiquid biopsiesMolecular targetsMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (48)

|Oct 27, 2026
A Long-Acting Farnesoid X Receptor (FXR) Agonist Prevents Fibrosis.

|Apr 17, 2026
Sex- and Age-Dependent Neuroimmune Dysregulation and Early Neurodegenerative Signatures Following SARS-CoV-2 Infection in Golden Syrian Hamsters.

|Apr 05, 2026
Carcinogenicity Risk Assessment of Agrochemicals and Pharmaceuticals.

Xavier Palazzi, Samuel M Cohen, Stephanie Melching-Kollmuss

|Apr 02, 2026
Mode of action (MOA) for nasal tumors induced by methyl isothiocyanate (MITC) in Sprague Dawley rats.

Melissa Badding, B Bhaskar Gollapudi, Richard Reiss

|Mar 27, 2026
Carcinogenicity in the 21st Century: Challenges of New Methodologies, Strategies, and Their Impact on Pathologists-Session 1.

Dirk Schaudien, Samuel M Cohen, Helen-Marie Dunmore

|Jan 21, 2026
An ultra-long-acting dimeric bictegravir prodrug defined by a short pharmacokinetic tail.

Mohammad Ullah Nayan, Brady Sillman, Srijanee Das

Pageof 8

Frequent Collaborators

9 joint publications

Howard Gendelman

7 joint publications

Benson J Edagwa

7 joint publications

Tomoya Yamada

4 joint publications

Srijanee Das